Group 1 - A new company, Zhenjiang Guangjian Glasses Co., Ltd., has been established with a registered capital of 50,000 RMB [1] - The legal representative of the company is Ke Shengquan [1] - The business scope includes various sales activities such as eyewear (excluding contact lenses), optical glass, and wearable smart devices [1] Group 2 - The company is also involved in internet sales, daily necessities sales, and clothing wholesale and retail [1] - Additional services offered include professional design services, advertising design and agency, and business consulting [1] - The company is permitted to engage in domestic cargo transportation agency and trade agency services [1]

Core Viewpoint - The company, Dr. Optical (300622.SZ), reported a revenue of 686 million yuan for the first half of 2025, reflecting a year-on-year growth of 14.22% [1] - The net profit attributable to shareholders reached 56.03 million yuan, marking a year-on-year increase of 6.97% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 49.65 million yuan, showing an 8.24% year-on-year growth [1] - The basic earnings per share stood at 0.25 yuan [1] Financial Performance - Revenue for the first half of 2025: 686 million yuan, up 14.22% year-on-year [1] - Net profit attributable to shareholders: 56.03 million yuan, up 6.97% year-on-year [1] - Net profit after deducting non-recurring items: 49.65 million yuan, up 8.24% year-on-year [1] - Basic earnings per share: 0.25 yuan [1]

Core Viewpoint - The company, 博士眼镜, reported a revenue of 686 million yuan for the first half of 2025, reflecting a year-on-year growth of 14.22%, and a net profit attributable to shareholders of 56.03 million yuan, which is a 6.97% increase compared to the previous year [1] Financial Performance - The company's operating revenue for the first half of 2025 reached 686 million yuan, marking a 14.22% increase year-on-year [1] - The net profit attributable to shareholders was 56.03 million yuan, showing a growth of 6.97% year-on-year [1] - Basic earnings per share stood at 0.25 yuan [1] Strategic Partnerships - The company has established collaborations with leading smart glasses manufacturers including 星纪魅族, 雷鸟创新, XREAL, 界环, 李未可, 小米mijia, and 雷神科技 [1] - The revenue from the company's smart glasses lens fitting services is currently minimal and will not significantly impact the company's operations in the short term [1]

Core Viewpoint - The company reported a revenue of 686 million yuan for the first half of 2025, representing a year-on-year growth of 14.22% and a net profit of 56.03 million yuan, which is a 6.97% increase compared to the previous year [1] Financial Performance - Revenue for the first half of 2025 reached 686 million yuan, showing a year-on-year increase of 14.22% [1] - Net profit for the same period was 56.03 million yuan, reflecting a growth of 6.97% year-on-year [1] Dividend Policy - The company announced that it will not distribute cash dividends, issue bonus shares, or increase capital through reserves [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 博士眼镜连锁股份有限公司于近日发布关于特定股东减持股份的预披露公告。公告显示，持有公司股份 241.74万股（占公司总股本比例1.0609%）的特定股东江西江南道企业管理有限公司（原深圳市江南道 投资有限责任公司，以下简称"江南道"），计划在本公告披露之日起3个交易日后的3个月内，即2025年 8月29日 - 2025年11月28日（在此期间如遇相关法律法规、规范性文件规定的窗口期则不减持），以集 中竞价或大宗交易方式减持公司股份不超过97.29万股（占本公司总股本比例0.4270%）。 减持原因及股份来源 江南道此次减持原因是自身资金需求，其持股股份来源未在公告中特别说明。截至公告披露日，公司总 股本是227,854,160股 ，江南道持股2,417,401股，占公司总股本比例1.0609%。 减持方式及相关限制 减持方式包括集中竞价或大宗交易。若采取集中竞价交易方式，在任意连续90日内，减持股份的总数不 超过公司总股本的1%；若采取大宗交易方式，在任意连续90日内，减持股份的总数不超过公司总股本 的2%。减持价格将根据减持时的二级市场价格及交易方式确定。 ...

Core Viewpoint - The company Dr. Optical (300622.SZ) announced that a specific shareholder, Jiangnan Dao, plans to reduce its holdings by up to 970,000 shares, accounting for 0.4270% of the company's total share capital, due to personal funding needs [1] Summary by Relevant Sections - Shareholder Reduction Plan - Jiangnan Dao intends to reduce its stake in the company through centralized bidding or block trading [1] - The reduction period is set from August 29, 2025, to November 28, 2025 [1] - The maximum number of shares to be sold is 970,000 [1]

天眼查App显示，近日，化德县欧阳眼镜店（个人独资）成立，法定代表人为潘新水，注册资本1万人 民币，经营范围为许可项目：第三类医疗器械经营。（依法须经批准的项目，经相关部门批准后方可开 展经营活动，具体经营项目以相关部门批准文件或许可证件为准）一般项目：眼镜销售（不含隐形眼 镜）；眼镜制造；光学玻璃销售；日用品销售；化妆品零售；钟表销售。（除依法须经批准的项目外， 凭营业执照依法自主开展经营活动）。 ...

Core Viewpoint - Hefei Huiyun Chuyayanjing Co., Ltd. has been established with a registered capital of 30,000 RMB, focusing on various technology services and sales in the optical and electronic sectors [1] Company Overview - The company is represented by Sun Hui and has a registered capital of 30,000 RMB [1] - The business scope includes technology services, development, consulting, and promotion, as well as sales of optical and electronic products [1] Business Scope - General projects include technology services, development, consulting, and promotion [1] - Sales activities cover a wide range of products such as optical devices, optical glass, electronic components, personal hygiene products, and medical supplies [1] - The company is also involved in retail sales of cosmetics, daily necessities, sports equipment, and office supplies [1] Regulatory Compliance - The company is authorized to operate third-class medical devices, subject to approval from relevant authorities [1]

Group 1 - The stock price of 博士眼镜 (Doctor Glasses) closed at 33.78 yuan on July 29, down by 0.71 yuan, representing a decline of 2.06% [1] - The trading volume on that day was 108,619 hands, with a total transaction amount of 367 million yuan [1] - 博士眼镜 operates in the commercial retail sector, primarily focusing on eyewear retail chain operations, with brands such as 博士眼镜 and President Optical [1] Group 2 - On July 29, the company stated on its interactive platform that it is currently using artificial intelligence technology to enhance existing business efficiency and service experience, but has not independently developed or operated AI products or platforms with complex autonomous decision-making capabilities [1] - On the same day, the net outflow of main funds was 56.6 million yuan, accounting for 1.08% of the circulating market value [1]

证券日报网讯博士眼镜（300622）7月29日在互动平台回答投资者提问时表示，公司目前主要将人工智 能技术作为提升现有业务效率和服务体验的辅助工具，公司未独立研发或运营具有复杂自主决策能力的 AI智能体相关产品或平台。 ...